February 26, 2020 / 10:45 PM / a month ago

BRIEF-Sarepta Therapeutics Posts Non-GAAP Loss Per Share Of $1.57

Feb 26 (Reuters) - Sarepta Therapeutics Inc:

* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS

* Q4 NON-GAAP LOSS PER SHARE $1.57

* Q4 REVENUE $100.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $98.9 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $-1.86 — REFINITIV IBES DATA

* HAD APPROXIMATELY $1.1 BILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS AS OF DECEMBER 31, 2019

* SAREPTA THERAPEUTICS- QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $3.16 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below